
@article{chen_apobec3a_2017,
	title = {{APOBEC3A} is an oral cancer prognostic biomarker in {Taiwanese} carriers of an {APOBEC} deletion polymorphism},
	volume = {8},
	issn = {20411723},
	doi = {10.1038/s41467-017-00493-9},
	abstract = {Â© 2017 The Author(s). Oral squamous cell carcinoma is a prominent cancer worldwide, particularly in Taiwan. By integrating omics analyses in 50 matched samples, we uncover in Taiwanese patients a predominant mutation signature associated with cytidine deaminase APOBEC, which correlates with the upregulation of APOBEC3A expression in the APOBEC3 gene cluster at 22q13. APOBEC3A expression is significantly higher in tumors carrying APOBEC3B-deletion allele(s). High-level APOBEC3A expression is associated with better overall survival, especially among patients carrying APOBEC3B-deletion alleles, as examined in a second cohort (n = 188; p = 0.004). The frequency of APOBEC3B-deletion alleles is {\textasciitilde}50\% in 143 genotyped oral squamous cell carcinoma -Taiwan samples (27A3B -/-:89A3B +/-:27A3B +/+), compared to the 5.8\% found in 314 OSCC-TCGA samples. We thus report a frequent APOBEC mutational profile, which relates to a APOBEC3B-deletion germline polymorphism in Taiwanese oral squamous cell carcinoma that impacts expression of APOBEC3A, and is shown to be of clinical prognostic relevance. Our finding might be recapitulated by genomic studies in other cancer types.},
	number = {1},
	journal = {Nature Communications},
	author = {Chen, T.-W. and Lee, C.-C. and Liu, H. and Wu, C.-S. and Pickering, C.R. and Huang, P.-J. and Wang, J. and Chang, I.Y.-F. and Yeh, Y.-M. and Chen, C.-D. and Li, H.-P. and Luo, J.-D. and Tan, B.C.-M. and Chan, T.E.H. and Hsueh, C. and Chu, L.J. and Chen, Y.-T. and Zhang, B. and Yang, C.-Y. and Wu, C.-C. and Hsu, C.-W. and See, L.-C. and Tang, P. and Yu, J.-S. and Liao, W.-C. and Chiang, W.-F. and Rodriguez, H. and Myers, J.N. and Chang, K.-P. and Chang, Y.-S.},
	year = {2017},
}
